Brainstorm Cell Therapeutics Inc. SEC filings BCLI

Brainstorm Cell Therapeutics Inc. has 949 filings in SEC EDGAR's recent list, going back to May 24, 2001. Its latest annual report, Form 10-K, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 14, 2026 (results of operations). The company's fiscal year ends on December 31.

Form Description Filed Period
10-K Annual report Mar 31, 2026 Dec 31, 2025
ARS Annual report to shareholders May 16, 2025 Dec 31, 2024
10-K Annual report Mar 31, 2025 Dec 31, 2024
ARS Annual report to shareholders Aug 16, 2024 Dec 31, 2023
10-K Annual report Apr 1, 2024 Dec 31, 2023
10-K Annual report Mar 30, 2023 Dec 31, 2022
10-K Annual report Mar 28, 2022 Dec 31, 2021
10-K Annual report Feb 4, 2021 Dec 31, 2020
10-K Annual report Feb 18, 2020 Dec 31, 2019
10-K/A Amended annual report Apr 1, 2019 Dec 31, 2018
10-K Annual report Mar 29, 2019 Dec 31, 2018
10-K Annual report Mar 8, 2018 Dec 31, 2017
10-K Annual report Mar 29, 2017 Dec 31, 2016
10-K Annual report Mar 9, 2016 Dec 31, 2015
ARS Annual report to shareholders Jul 20, 2015 Dec 31, 2014
10-K Annual report Mar 26, 2015 Dec 31, 2014
ARS Annual report to shareholders Jul 28, 2014 Dec 31, 2013
10-K Annual report Mar 27, 2014 Dec 31, 2013
ARS Annual report to shareholders Mar 26, 2013 Dec 31, 2012
10-K Annual report Mar 14, 2013 Dec 31, 2012
ARS Annual report to shareholders May 11, 2012 Dec 31, 2011
10-K Annual report Mar 15, 2012 Dec 31, 2011
10-K/A Amended annual report Dec 28, 2011 Dec 31, 2010
ARS Annual report to shareholders May 11, 2011 Dec 31, 2010
10-K Annual report Mar 31, 2011 Dec 31, 2010
ARS Annual report to shareholders May 5, 2010 Dec 31, 2009
10-K Annual report Mar 25, 2010 Dec 31, 2009
10-K Annual report Apr 15, 2009 Dec 31, 2008
ARS Annual report to shareholders May 2, 2008 Dec 31, 2007
ARS Annual report to shareholders Aug 25, 2006 Mar 31, 2006

Showing 30 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
BCLI (OTC)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
New York, NY
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1137883
Former names
BRAINSTORM CELL THERAPEUTICS INC (until Jul 23, 2012); GOLDEN HAND RESOURCES INC (until Nov 22, 2004); WIZBANG TECHNOLOGIES INC (until Aug 8, 2003)

Other Biological Products, (No Diagnostic Substances) companies

All 182 Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.